By Dr. Samuel Ting Chuo Yew President, Sarawak Society for Cell and Gene Therapy Research (SSCTR) The Ministry of Health Malaysia and the National Pharmaceutical Regulatory Agency (NPRA) have recently issued two landmark documents that define the national framework governing the use, research, and regulation of advanced cellular and genetic therapies in Malaysia. These are the “Guidance Document and Guidelines for Registration of Cell and Gene Therapy Products (CGTPs)” publis

Dear Members, I hope this message finds you well. On behalf of the Sarawak Society for Cell and Gene Therapy Research (SSCTR), I am...

On 9 July 2025, I had the privilege of attending the Value-Based Healthcare (VBHC) Conference 2025, organized by the Pharmaceutical...

In recent years, public interest in stem cell therapy has surged, often fueled by promises of anti-aging, disease reversal, and...